Restatement of Previously Issued Financial Statements (Tables)

12 Months Ended

Dec. 31, 2020

Condensed Financial Information Disclosure [Abstract]

Schedule of impact of the restatement on financial statements

	As Previously Reported			Adjustments			As Restated
Balance sheet as of September 8, 2020
Warrant Liabilities	$	-		$	13,592,898		$	13,592,898
Total Liabilities		9,801,183			13,592,898			23,394,081
Common Stock Subject to Possible Redemption		216,189,340			13,810,660			230,000,000
Class A Common Stock		192			(138	)		54
Additional Paid-in Capital		5,000,863			(5,000,863	)		0
Accumulated Deficit		(1,740	)		(22,400,652	)		(22,402,392	)
Balance sheet as of December 31, 2020
Warrant Liabilities	$	-		$	27,837,928		$	27,837,928
Total Liabilities		9,925.075			27,837,928			37,763,003
Common Stock Subject to Possible Redemption		215,618,860			14,381,140			230,000,000
Class A Common Stock		198			(144	)		54
Additional Paid-in Capital		5,571,241			(5,571,241	)		0
Accumulated Deficit		(572,217	)		(36,647,683	)		(37,219,900	)
Year-ended December 31, 2020
Change in fair value of warrant liabilities	$	-		$	14,245,031		$	14,245,031
Transaction costs allocable to warrant liabilities		-			820,852			820,852
Net loss		(571,093	)		(15,065,883	)		(15,636,976	)
Basic and diluted net loss per share, Class A common stock		(0.00	)		(0.51	)		(0.51	)
Basic and diluted net loss per share, Class B common stock		(0.07	)		(0.44	)		(0.51	)
Cash Flow Statement for the year ended December 31, 2020
Net loss	$	(571,093	)	$	(15,065,883	)	$	(15,636,976	)
Change in fair value of warrant liabilities		-			14,245,031			14,245,031
Transaction costs allocable to warrant liabilities		-			820,852			820,852